Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-2141-2020

Accelerator a3600 Automation System with Advia2120LAS Interface Module (P/N FLX-219-00, FLX-219-10), ImmunoCAP 1000 Interface Module (P/N FLX-226-01, FLX-226-10), or StaRRsed Interface Module (P/N FLX-268-00) is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The systems consolidate multiple Analytical instruments into a unified workstation.

Publicado el 3 de junio de 2020 · Inicio del retiro: 7 de abril de 2020

Resumen

FDA registra el retiro Z-2141-2020 de dispositivos médicos de Clase II, publicado el 3 de junio de 2020 e iniciado el 7 de abril de 2020. Empresa responsable: Inpeco S.A.; Estado: Finalizado; Cantidad reportada: 3 systems; Lote: Serial Numbers: ACP.290 ACP.343 ACP.365. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

The identified problem is an erroneous association between the carrier and the sample tube caused by a communication error between the firmware of the Interface Modules and the Automation software. This problem can occur only when one of these Interface Modules is put off-line after a carrier in their secondary lane is physically returned on the main track and then put back on-line when the carrier is used to transport another tube.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Inpeco S.A.
Distribuidor
US Nationwide including in the states of IL, NY.
Lote
Serial Numbers: ACP.290 ACP.343 ACP.365
Clasificación de riesgo
Class II
Área (FDA)
device
País
Switzerland

Retiros relacionados

Preguntas sobre este retiro

¿Accelerator a3600 Automation System with Advia2120LAS Interface Module (P/N FLX-219-00, FLX-219-10), ImmunoCAP 1000 Interface Module (P/N FLX-226-01, FLX-226-10), or StaRRsed Interface Module (P/N FLX-268-00) is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The systems consolidate multiple Analytical instruments into a unified workstation. fue retirado del mercado?

Sí. FDA publicó el retiro Z-2141-2020 el 3 de junio de 2020. Peligro reportado: The identified problem is an erroneous association between the carrier and the sample tube caused by a communication error between the firmware of the Interface Modules and the Automation software. This problem can occur only when one of these Interface Modules is put off-line after a carrier in their secondary lane is physically returned on the main track and then put back on-line when the carrier is used to transport another tube.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter